vs
Side-by-side financial comparison of AMN HEALTHCARE SERVICES INC (AMN) and Chemours Co (CC). Click either name above to swap in a different company.
Chemours Co is the larger business by last-quarter revenue ($1.3B vs $748.2M, roughly 1.8× AMN HEALTHCARE SERVICES INC). AMN HEALTHCARE SERVICES INC runs the higher net margin — -1.0% vs -3.5%, a 2.5% gap on every dollar of revenue. On growth, AMN HEALTHCARE SERVICES INC posted the faster year-over-year revenue change (1.8% vs -2.1%). Chemours Co produced more free cash flow last quarter ($92.0M vs $67.6M). Over the past eight quarters, Chemours Co's revenue compounded faster (-1.2% CAGR vs -4.5%).
AMN Healthcare Services Inc. is a leading US healthcare sector workforce solutions and staffing provider. It offers temporary and permanent placement for nurses, physicians, allied health and other clinical/non-clinical staff, plus workforce management tools and consulting for hospitals, clinics and other medical facilities.
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
AMN vs CC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $748.2M | $1.3B |
| Net Profit | $-7.7M | $-47.0M |
| Gross Margin | 26.1% | 11.7% |
| Operating Margin | 1.1% | — |
| Net Margin | -1.0% | -3.5% |
| Revenue YoY | 1.8% | -2.1% |
| Net Profit YoY | 95.9% | -261.5% |
| EPS (diluted) | $-0.19 | $-0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $748.2M | $1.3B | ||
| Q3 25 | $634.5M | $1.5B | ||
| Q2 25 | $658.2M | $1.6B | ||
| Q1 25 | $689.5M | $1.4B | ||
| Q4 24 | $734.7M | $1.4B | ||
| Q3 24 | $687.5M | $1.5B | ||
| Q2 24 | $740.7M | $1.6B | ||
| Q1 24 | $820.9M | $1.4B |
| Q4 25 | $-7.7M | $-47.0M | ||
| Q3 25 | $29.3M | $46.0M | ||
| Q2 25 | $-116.2M | $-380.0M | ||
| Q1 25 | $-1.1M | $-5.0M | ||
| Q4 24 | $-187.5M | $-13.0M | ||
| Q3 24 | $7.0M | $-32.0M | ||
| Q2 24 | $16.2M | $60.0M | ||
| Q1 24 | $17.3M | $54.0M |
| Q4 25 | 26.1% | 11.7% | ||
| Q3 25 | 29.1% | 15.6% | ||
| Q2 25 | 29.8% | 17.2% | ||
| Q1 25 | 28.7% | 17.3% | ||
| Q4 24 | 29.8% | 19.4% | ||
| Q3 24 | 31.0% | 19.0% | ||
| Q2 24 | 31.0% | 19.8% | ||
| Q1 24 | 31.4% | 20.9% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 7.5% | 2.5% | ||
| Q2 25 | -18.8% | -15.4% | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | -27.6% | -0.1% | ||
| Q3 24 | 3.2% | -2.1% | ||
| Q2 24 | 5.1% | 4.4% | ||
| Q1 24 | 4.9% | 5.1% |
| Q4 25 | -1.0% | -3.5% | ||
| Q3 25 | 4.6% | 3.1% | ||
| Q2 25 | -17.7% | -23.5% | ||
| Q1 25 | -0.2% | -0.4% | ||
| Q4 24 | -25.5% | -1.0% | ||
| Q3 24 | 1.0% | -2.1% | ||
| Q2 24 | 2.2% | 3.9% | ||
| Q1 24 | 2.1% | 4.0% |
| Q4 25 | $-0.19 | $-0.32 | ||
| Q3 25 | $0.76 | $0.31 | ||
| Q2 25 | $-3.02 | $-2.53 | ||
| Q1 25 | $-0.03 | $-0.03 | ||
| Q4 24 | $-4.90 | $-0.07 | ||
| Q3 24 | $0.18 | $-0.22 | ||
| Q2 24 | $0.42 | $0.39 | ||
| Q1 24 | $0.45 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $670.0M |
| Total DebtLower is stronger | $767.1M | $4.1B |
| Stockholders' EquityBook value | $642.1M | $250.0M |
| Total Assets | $2.1B | $7.4B |
| Debt / EquityLower = less leverage | 1.19× | 16.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.0M | $670.0M | ||
| Q3 25 | $52.6M | $613.0M | ||
| Q2 25 | $41.5M | $502.0M | ||
| Q1 25 | $55.8M | $464.0M | ||
| Q4 24 | $10.6M | $713.0M | ||
| Q3 24 | $30.6M | $596.0M | ||
| Q2 24 | $48.0M | $604.0M | ||
| Q1 24 | $50.6M | $746.0M |
| Q4 25 | $767.1M | $4.1B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | — | $4.1B | ||
| Q4 24 | $1.1B | $4.1B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $4.0B | ||
| Q1 24 | — | $4.0B |
| Q4 25 | $642.1M | $250.0M | ||
| Q3 25 | $644.4M | $274.0M | ||
| Q2 25 | $607.6M | $228.0M | ||
| Q1 25 | $715.1M | $566.0M | ||
| Q4 24 | $706.6M | $571.0M | ||
| Q3 24 | $890.7M | $643.0M | ||
| Q2 24 | $876.9M | $714.0M | ||
| Q1 24 | $854.2M | $753.0M |
| Q4 25 | $2.1B | $7.4B | ||
| Q3 25 | $2.1B | $7.5B | ||
| Q2 25 | $2.2B | $7.5B | ||
| Q1 25 | $2.4B | $7.4B | ||
| Q4 24 | $2.4B | $7.5B | ||
| Q3 24 | $2.7B | $7.5B | ||
| Q2 24 | $2.8B | $7.2B | ||
| Q1 24 | $2.9B | $8.0B |
| Q4 25 | 1.19× | 16.40× | ||
| Q3 25 | — | 14.96× | ||
| Q2 25 | — | 17.99× | ||
| Q1 25 | — | 7.18× | ||
| Q4 24 | 1.49× | 7.11× | ||
| Q3 24 | — | 6.20× | ||
| Q2 24 | — | 5.53× | ||
| Q1 24 | — | 5.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.6M | $137.0M |
| Free Cash FlowOCF − Capex | $67.6M | $92.0M |
| FCF MarginFCF / Revenue | 9.0% | 6.9% |
| Capex IntensityCapex / Revenue | 1.1% | 3.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $233.8M | $51.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.6M | $137.0M | ||
| Q3 25 | $22.7M | $146.0M | ||
| Q2 25 | $78.5M | $93.0M | ||
| Q1 25 | $92.7M | $-112.0M | ||
| Q4 24 | $72.8M | $138.0M | ||
| Q3 24 | $66.7M | $139.0M | ||
| Q2 24 | $99.5M | $-620.0M | ||
| Q1 24 | $81.4M | $-290.0M |
| Q4 25 | $67.6M | $92.0M | ||
| Q3 25 | $14.8M | $105.0M | ||
| Q2 25 | $68.7M | $50.0M | ||
| Q1 25 | $82.7M | $-196.0M | ||
| Q4 24 | $56.6M | $29.0M | ||
| Q3 24 | $47.4M | $63.0M | ||
| Q2 24 | $72.2M | $-693.0M | ||
| Q1 24 | $63.2M | $-392.0M |
| Q4 25 | 9.0% | 6.9% | ||
| Q3 25 | 2.3% | 7.0% | ||
| Q2 25 | 10.4% | 3.1% | ||
| Q1 25 | 12.0% | -14.3% | ||
| Q4 24 | 7.7% | 2.1% | ||
| Q3 24 | 6.9% | 4.2% | ||
| Q2 24 | 9.8% | -44.6% | ||
| Q1 24 | 7.7% | -28.8% |
| Q4 25 | 1.1% | 3.4% | ||
| Q3 25 | 1.2% | 2.7% | ||
| Q2 25 | 1.5% | 2.7% | ||
| Q1 25 | 1.4% | 6.1% | ||
| Q4 24 | 2.2% | 8.0% | ||
| Q3 24 | 2.8% | 5.0% | ||
| Q2 24 | 3.7% | 4.7% | ||
| Q1 24 | 2.2% | 7.5% |
| Q4 25 | — | — | ||
| Q3 25 | 0.77× | 3.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.54× | — | ||
| Q2 24 | 6.13× | -10.33× | ||
| Q1 24 | 4.70× | -5.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
